文献速递乳腺技术与安全

SAFE微波乳腺病灶分类系统的临床研究结果

Microwave Breast Lesion Classification - Results from Clinical Investigation of the SAFE Microwave Breast Cancer System.
PubMed 文献 · Acad Radiol · 2022-12-21

研究评估SAFE微波乳腺成像系统对BI-RADS 4或5类待活检病灶的良恶性分类能力,采用AdaBoost机器学习模型分析113例样本(70例良性、43例恶性),获得敏感度79%、特异度77%、准确率78%的分类表现。装置对良恶性病灶的识别率相近,非电离非侵入特性有望用于乳腺癌筛查与早期检测。

要点

  • SAFE微波成像对BI-RADS 4/5类病灶良恶性分类:敏感度79%、特异度77%、准确率78%。
  • 研究基于113例乳腺样本(70例良性、43例恶性),采用AdaBoost机器学习模型。
  • 微波成像为非电离、非侵入技术,有望补充乳腺癌筛查与早期检测。
英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Microwave breast cancer imaging (MWI) is an emerging non-invasive technology used to clinically assess the internal breast tissue inhomogeneity. MWI utilizes the variance in dielectric properties of healthy and cancerous tissue to identify anomalies inside the breast and make further clinical predictions. In this study, we evaluate our SAFE MWI system in a clinical setting. Capability of SAFE to provide breast pathology is assessed.

MATERIALS AND METHODS: Patients with BI-RADS category 4 or 5 who were scheduled for biopsy were included in the study. Machine learning approach, more specifically the Adaptive Boosting (AdaBoost) model, was implemented to determine if the level of difference between backscattered signals of breasts with the benign and malignant pathological outcome is significant enough for quantitative breast health classification via SAFE.

RESULTS: A dataset of 113 (70 benign and 43 malignant) breast samples was used in the study. The proposed classification model achieved the sensitivity, specificity, and accuracy of 79%, 77%, and 78%, respectively.

CONCLUSION: The non-ionizing and non-invasive nature gives SAFE an opportunity to impact breast cancer screening and early detection positively. Device classified both benign and malignant lesions at a similar rate. Further clinical studies are planned to validate the findings of this study.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Janjic, Akduman, Cayoren, et al. Microwave Breast Lesion Classification - Results from Clinical Investigation of the SAFE Microwave Breast Cancer System. Acad Radiol. 2022. PMID: 36549991. doi:10.1016/j.acra.2022.12.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。